Cargando…

Assessment of the Potential Herpes Zoster and Post Herpetic Neuralgia Case Avoidance with Vaccination in the United States

BACKGROUND: Herpes zoster (HZ), commonly referred to as shingles, is a reactivation of latent varicella zoster virus in patients previously infected. Clinical characteristics of HZ include painful rash with potential complications, including post herpetic neuralgia (PHN). Care for HZ and PHN incurs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patterson, Brandon J, Buck, Philip O, Carrico, Justin, Hicks, Katherine A, Curran, Desmond, Van Oorschot, Desiree, Pawlowski, John E, Lee, Bruce Y, Yawn, Barbara P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631384/ http://dx.doi.org/10.1093/ofid/ofx163.1034

Ejemplares similares

Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live
por: Curran, Desmond, et al.
Publicado: (2019)

Burden of herpes zoster and post-herpetic neuralgia in Sweden
por: Nilsson, Jonas, et al.
Publicado: (2015)

Meta-Regression of Herpes Zoster Incidence Worldwide
por: Curran, Desmond, et al.
Publicado: (2021)

A systematic literature review of herpes zoster incidence worldwide
por: van Oorschot, Désirée, et al.
Publicado: (2021)

The impact of herpes zoster and post-herpetic neuralgia on quality-of-life
por: Johnson, Robert W, et al.
Publicado: (2010)

1440. Meta-regression Analysis of Worldwide Herpes Zoster Incidence
por: Yawn, Barbara P, et al.
Publicado: (2021)

Estimated Public Health Impact of the Recombinant Zoster Vaccine
por: Patterson, Brandon J., et al.
Publicado: (2021)

20. Cost-Effectiveness of Recombinant Zoster Vaccine for Vaccinating Immunocompromised Adults Against Herpes Zoster in the United States
por: Curran, Desmond, et al.
Publicado: (2021)

Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer
por: Curran, Desmond, et al.
Publicado: (2023)

Herpes zoster in pregnancy leading to keloids and post herpetic neuralgia: A double whammy?
por: Verma, Shyam B., et al.
Publicado: (2013)

Herpes zoster and severe acute herpetic neuralgia as a complication of COVID-19 infection
por: Shors, Andrew R.
Publicado: (2020)

Herpes Zoster Vaccine Effectiveness against Incident Herpes Zoster and Post-herpetic Neuralgia in an Older US Population: A Cohort Study
por: Langan, Sinéad M., et al.
Publicado: (2013)

Measuring the burden of herpes zoster and post herpetic neuralgia within primary care in rural Crete, Greece
por: Lionis, Christos D, et al.
Publicado: (2011)

A Cost-Effectiveness Analysis of an Adjuvanted Subunit Vaccine for the Prevention of Herpes Zoster and Post-Herpetic Neuralgia
por: Carpenter, Christopher, et al.
Publicado: (2017)

A Cost-effectiveness Analysis of an Adjuvanted Subunit Vaccine for the Prevention of Herpes Zoster and Post-herpetic Neuralgia
por: Carpenter, Christopher F, et al.
Publicado: (2019)

A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK
por: Moore, Lee, et al.
Publicado: (2010)

Impact of herpes zoster and post-herpetic neuralgia on patients’ quality of life: a patient-reported outcomes survey
por: Weinke, Thomas, et al.
Publicado: (2010)

The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countries
por: Lukas, Kati, et al.
Publicado: (2011)

Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: A retrospective, population-based study
por: Gialloreti, Leonardo Emberti, et al.
Publicado: (2010)

Persistence of a T Cell Infiltrate in Human Ganglia Years After Herpes Zoster and During Post-herpetic Neuralgia
por: Sutherland, Jeremy P., et al.
Publicado: (2019)

Impact of Herpes Zoster and Post-Herpetic Neuralgia on Health-Related Quality of Life in Japanese Adults Aged 60 Years or Older: Results from a Prospective, Observational Cohort Study
por: Mizukami, Akiko, et al.
Publicado: (2017)

Assessment of the potential public health impact of Herpes Zoster vaccination in Germany
por: Curran, Desmond, et al.
Publicado: (2017)

Challenges in quantifying the patient-reported burden of herpes zoster and post-herpetic neuralgia in the UK: learnings from the Zoster Quality of Life (ZQOL) study
por: Carroll, Stuart, et al.
Publicado: (2013)

Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above
por: Curran, Desmond, et al.
Publicado: (2018)

Incidence of herpes zoster and post-herpetic neuralgia in Italy: Results from a 3-years population-based study
por: Alicino, Cristiano, et al.
Publicado: (2016)

Metabolomics profiling in predicting of post-herpetic neuralgia induced by varicella zoster
por: Lu, Lina, et al.
Publicado: (2023)

Incremental clinical and economic impact of recombinant zoster vaccination: real-world data in a budget impact model
por: Patterson, Brandon J, et al.
Publicado: (2020)

Herpes zoster ophthalmicus: Pre-eruption phase sine herpete
por: Sigireddi, Rohini R., et al.
Publicado: (2018)

Economic Burden of Herpes Zoster and Post-Herpetic Neuralgia in Adults 60 Years of Age or Older: Results from a Prospective, Physician Practice-Based Cohort Study in Kushiro, Japan
por: Nakamura, Hiroyuki, et al.
Publicado: (2017)

A Cross-Sectional Concept Elicitation Study to Understand the Impact of Herpes Zoster on Patients’ Health-Related Quality of Life
por: Van Oorschot, Desirée, et al.
Publicado: (2022)

Post-herpetic neuralgia
por: Tontodonati, Monica, et al.
Publicado: (2012)

Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany
por: Préaud, Emmanuelle, et al.
Publicado: (2015)

The Potential Public Health Impact of Herpes Zoster Vaccination of People Aged ≥ 50 Years in Japan: Results of a Markov Model Analysis
por: Watanabe, Daisuke, et al.
Publicado: (2018)

Healthy ageing: Herpes zoster infection and the role of zoster vaccination
por: Curran, Desmond, et al.
Publicado: (2023)

The potential public health impact of Herpes Zoster vaccination in the 65 years of age cohort in Italy
por: Volpi, Antonio, et al.
Publicado: (2019)

FV‐100 versus valacyclovir for the prevention of post‐herpetic neuralgia and the treatment of acute herpes zoster‐associated pain: A randomized‐controlled trial
por: Tyring, Stephen K., et al.
Publicado: (2016)

Impact of Type 1 Versus Type 2 Diabetes on Developing Herpes Zoster and Post-herpetic Neuralgia: A Population-based Cohort Study
por: WEN, Su-Ying, et al.
Publicado: (2023)

The Economic Burden and Impact on Quality of Life of Herpes Zoster and Postherpetic Neuralgia in Individuals Aged 50 Years or Older in Italy
por: Matthews, Sean, et al.
Publicado: (2019)

Trigeminal Herpes Zoster Transited to Ipsilateral Occipital Neuralgia
por: Takizawa, Keita, et al.
Publicado: (2022)

The temporal impact of aging on the burden of herpes zoster
por: Varghese, Lijoy, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_aank984338o8t290sau96kap6v